Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Maropitant for Nausea and Vomiting Support in Cancer Care
Maropitant is a prescription antiemetic used for selected dogs and cats, but controlling vomiting does not identify or resolve every cause of nausea or gastrointestinal disease.
Read more
Ondansetron for Persistent Nausea: Role and Interaction Review
Ondansetron is a serotonin-receptor antiemetic used by veterinarians for selected nausea and vomiting, often when one pathway or medicine is not enough.
Read more
Metoclopramide: Antiemetic and Motility Questions in Oncology
Metoclopramide has antiemetic and upper-gastrointestinal motility effects, making obstruction, neurologic history, cause, route, and interactions central to safe selection.
Read more
Gabapentin as an Adjunct in Cancer Pain Plans
Gabapentin may be one component of multimodal pain or anxiety support, but effectiveness varies and sedation, weakness, kidney function, and compounded products need review.
Read more
Pregabalin as a Neuropathic-Pain Adjunct: Evidence and Sedation Review
Pregabalin is a prescription neuromodulator considered for selected pain plans, with limited oncology-specific evidence and meaningful sedation and coordination risks.
Read more
Bisphosphonates for Tumor-Associated Bone Pain
Intravenous bisphosphonates may be considered for selected tumor-associated bone pain or skeletal complications, with kidney, mineral, dental, and infusion review.
Read more
Named profile Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea SupportRepresentative category illustration – no product packaging is shown.Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea Support
crofelemer delayed-release tablets is covered as prescription antisecretory gastrointestinal medicine; supportive care, not antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in Oncology
bedinvetmab is covered as canine monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in Oncology
frunevetmab is covered as feline monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Acid-Suppression Medicines in Veterinary Oncology: Rational-Use ProfileRepresentative category illustration – no product packaging is shown.Acid-Suppression Medicines in Veterinary Oncology: Rational-Use Profile
proton-pump inhibitors and histamine-2 receptor antagonists is covered as gastrointestinal supportive-medicine class, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Cobalamin (Vitamin B12) in Canine and Feline Oncology SupportRepresentative category illustration – no product packaging is shown.Cobalamin (Vitamin B12) in Canine and Feline Oncology Support
cobalamin (vitamin B12) is covered as nutrient replacement for documented or strongly suspected deficiency; not a universal cancer supplement, with species, evidence, regulatory, safety, interaction and monitoring boundaries…
Read more